These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 32329194)

  • 21. A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes.
    Baxter M; Morimoto Y; Tamiwa M; Hattori M; Peng XV; Lubwama R; Maegawa H
    Diabetes Ther; 2020 Jul; 11(7):1481-1496. PubMed ID: 32445125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study.
    Patel S; Abreu M; Tumyan A; Adams-Huet B; Li X; Lingvay I
    BMJ Open Diabetes Res Care; 2019; 7(1):e000761. PubMed ID: 31803482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HbA1c target achievement in the elderly: results of the Titration and Optimization trial for initiation of insulin glargine 100 U/mL in patients with type 2 diabetes poorly controlled on oral antidiabetic drugs.
    Fritsche A; Anderten H; Pfohl M; Pscherer S; Borck A; Pegelow K; Bramlage P; Seufert J
    BMJ Open Diabetes Res Care; 2019; 7(1):e000668. PubMed ID: 31423316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND).
    Tajima A; Tobe K; Eiki JI; Origasa H; Watada H; Shimomura I; Tokita S; Kadowaki T
    BMJ Open Diabetes Res Care; 2022 Dec; 10(6):. PubMed ID: 36585033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA.
    Mauricio D; Meneghini L; Seufert J; Liao L; Wang H; Tong L; Cali A; Stella P; Carita P; Khunti K
    Diabetes Obes Metab; 2017 Aug; 19(8):1155-1164. PubMed ID: 28251792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of baseline glycemia on outcomes with insulin glargine use in patients uncontrolled on oral agents.
    Banerji MA; Baron MA; Gao L; Blonde L
    Postgrad Med; 2014 May; 126(3):111-25. PubMed ID: 24918797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin Detemir in Combination with Oral Antidiabetic Drugs Improves Glycemic Control in Persons with Type 2 Diabetes in Near East Countries: Results from the Lebanese Subgroup.
    Echtay A; Andari E; Atallah P; Moufarrege R; Nemr R
    Ethn Dis; 2017 Jan; 27(1):45-54. PubMed ID: 28115821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The long-term efficacy of insulin glargine plus oral antidiabetic agents in a 32-month observational study of everyday clinical practice.
    Schreiber SA; Ferlinz K; Haak T
    Diabetes Technol Ther; 2008 Apr; 10(2):121-7. PubMed ID: 18260775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switching the basal insulin to insulin glargine 300 U/ml in people with type 2 diabetes under basal insulin supported oral therapy: Observational trial on effectiveness and safety.
    Seufert J; Wiesli P; Fritsche A; Anderten H; Pegelow K; Pscherer S; Pfohl M
    Diabetes Obes Metab; 2022 Jan; 24(1):72-81. PubMed ID: 34514696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unmet Needs of Glycaemic Control and Risk Factors of Residual Hyperglycaemia in a Chinese Population with Type 2 Diabetes Initiating Basal Insulin: A Post Hoc Analysis of the FPG GOAL Study.
    Wang X; Wu G; Shen D; Zhang X; Yang W
    Adv Ther; 2022 Jun; 39(6):2820-2830. PubMed ID: 35430674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of Fasting Glucose Levels on Achieving Glycemic Target in Individuals with Type 2 Diabetes: a Post Hoc Analysis.
    Ma J; Lei M; Li Y; Zhang X; Cui N; Yang W
    Adv Ther; 2020 Sep; 37(9):3816-3826. PubMed ID: 32671687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0.
    Owens DR; Landgraf W; Frier BM; Zhang M; Home PD; Meneghini L; Bolli GB
    Diabetes Obes Metab; 2019 Feb; 21(2):321-329. PubMed ID: 30520217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables.
    Ji LN; Lu JM; Guo XH; Yang WY; Weng JP; Jia WP; Zou DJ; Zhou ZG; Yu DM; Liu J; Shan ZY; Yang YZ; Hu RM; Zhu DL; Yang LY; Chen L; Zhao ZG; Li QF; Tian HM; Ji QH; Liu J; Ge JP; Shi LX; Xu YC
    BMC Public Health; 2013 Jun; 13():602. PubMed ID: 23800082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness and safety of initiation of once-daily insulin detemir in Chinese patients with type 2 diabetes previously treated with different quantities of oral anti-diabetic drugs: subgroup analysis of the Chinese SOLVE™ Study].
    Pan C; Ji L; Lu J; Yang W; Zhou Z;
    Zhonghua Nei Ke Za Zhi; 2015 Jul; 54(7):612-7. PubMed ID: 26359024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and safety of insulin glargine 300 unit/mL in Japanese type 2 diabetes mellitus patients: a 12-month post-marketing surveillance study (X-STAR study).
    Odawara M; Matsuhisa M; Hirose T; Koshida R; Senda M; Tanaka Y; Terauchi Y
    Expert Opin Pharmacother; 2020 Oct; 21(14):1771-1780. PubMed ID: 32693663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Status of basal-supported oral therapy in Chinese type 2 diabetic patients with inadequate glycemic control on oral anti-diabetic drugs.
    Xu W; Qiu L; Luo S; Li M; Weng J; Guo X; Ji L
    Diabetes Metab Res Rev; 2015 Nov; 31(8):796-802. PubMed ID: 26356031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and risk of hypoglycemia with use of insulin glargine or comparators in patients with cardiovascular risk factors.
    Blonde L; Baron MA; Zhou R; Banerji MA
    Postgrad Med; 2014 May; 126(3):172-89. PubMed ID: 24918802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study.
    Seufert J; Pegelow K; Bramlage P
    Vasc Health Risk Manag; 2013; 9():711-7. PubMed ID: 24259985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.